Schroder Global Recovery L Acc GBP
GlobalPricing frequency
Daily
Dealing cut off time
10:45
Type
OEIC
Yield
2.14%
NAV
£1.692
Income frequency
Annually
Ongoing charge
0.85%
Latest actual NAV date
13-11-2026
ISIN
GB00BYRJXP30
UCITS
Yes
Growth of 10k
Asset allocation
Top 10 holdings
| Holdings 31/10/2026 | % of assets |
|---|---|
| Bristol-Myers Squibb Co | 2.57 |
| Stanley Black & Decker Inc | 2.38 |
| Mohawk Industries Inc | 2.36 |
| Pfizer Inc | 2.29 |
| Sanofi SA | 2.26 |
| WPP PLC | 2.12 |
| John Wiley & Sons Inc Class A | 2.12 |
| Reckitt Benckiser Group PLC | 2.10 |
| Koninklijke Ahold Delhaize NV | 2.10 |
| The Swatch Group AG Bearer Shares | 2.09 |
Investment objective
The Fund aims to provide capital growth in excess of the MSCI World (Net Total Return) Index (after fees have been deducted) over a three to five year period by investing in equity and equity related securities of companies worldwide which are considered to be undervalued relative to their long term earnings potential. The Fund is actively managed and invests at least 80% of its assets in equity and equity related securities of companies worldwide that have suffered a set back in either share price or profitability, but where long term prospects are believed to be good.